Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections

Varsha Surendranath Taskar, R. R. Sharma, R. Goswami, P. J. John, A. A. Mahashur

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Bromhexeine has been widely used as an adjunct in the management of lower respiratory infections and is usefulin altering the physical characteristics of sputum. Its effect on the sputum penetration of an antibiotic has been sparsely studied. The present study highlights the improvement in sputum amoxycillin (amoxy) levels when a combination tablet, amoxy 500 mg plus bromhexeine 8 mg, is administered as compared to plain amoxy 500 mg. Sputum amoxy levels were significantly higher in the combination group (0.674 ± 0.588 μg ml ) as compared to 0.272±0.19 μg ml −1 in the amoxy group (P=0.028). The clinical responses assessed by the physician as well as the patient were significantly better in the amoxy plus bromhexeine group as compared to the amoxy group. The radiological and bacteriological responses were similar in both groups. There was no increase in the side-effects due to bromhexeine and, overall, its use can be recommended in the treatment of acute lower respiratory infections.

Original languageEnglish (US)
Pages (from-to)157-160
Number of pages4
JournalRespiratory Medicine
Volume86
Issue number2
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Amoxicillin
Sputum
Respiratory Tract Infections
Tablets
Anti-Bacterial Agents
Physicians

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections. / Taskar, Varsha Surendranath; Sharma, R. R.; Goswami, R.; John, P. J.; Mahashur, A. A.

In: Respiratory Medicine, Vol. 86, No. 2, 01.01.1992, p. 157-160.

Research output: Contribution to journalArticle

Taskar, Varsha Surendranath ; Sharma, R. R. ; Goswami, R. ; John, P. J. ; Mahashur, A. A. / Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections. In: Respiratory Medicine. 1992 ; Vol. 86, No. 2. pp. 157-160.
@article{c1559d32a60842078ed2c34361a89dd6,
title = "Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections",
abstract = "Bromhexeine has been widely used as an adjunct in the management of lower respiratory infections and is usefulin altering the physical characteristics of sputum. Its effect on the sputum penetration of an antibiotic has been sparsely studied. The present study highlights the improvement in sputum amoxycillin (amoxy) levels when a combination tablet, amoxy 500 mg plus bromhexeine 8 mg, is administered as compared to plain amoxy 500 mg. Sputum amoxy levels were significantly higher in the combination group (0.674 ± 0.588 μg ml − ) as compared to 0.272±0.19 μg ml −1 in the amoxy group (P=0.028). The clinical responses assessed by the physician as well as the patient were significantly better in the amoxy plus bromhexeine group as compared to the amoxy group. The radiological and bacteriological responses were similar in both groups. There was no increase in the side-effects due to bromhexeine and, overall, its use can be recommended in the treatment of acute lower respiratory infections.",
author = "Taskar, {Varsha Surendranath} and Sharma, {R. R.} and R. Goswami and John, {P. J.} and Mahashur, {A. A.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/S0954-6111(06)80233-7",
language = "English (US)",
volume = "86",
pages = "157--160",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections

AU - Taskar, Varsha Surendranath

AU - Sharma, R. R.

AU - Goswami, R.

AU - John, P. J.

AU - Mahashur, A. A.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Bromhexeine has been widely used as an adjunct in the management of lower respiratory infections and is usefulin altering the physical characteristics of sputum. Its effect on the sputum penetration of an antibiotic has been sparsely studied. The present study highlights the improvement in sputum amoxycillin (amoxy) levels when a combination tablet, amoxy 500 mg plus bromhexeine 8 mg, is administered as compared to plain amoxy 500 mg. Sputum amoxy levels were significantly higher in the combination group (0.674 ± 0.588 μg ml − ) as compared to 0.272±0.19 μg ml −1 in the amoxy group (P=0.028). The clinical responses assessed by the physician as well as the patient were significantly better in the amoxy plus bromhexeine group as compared to the amoxy group. The radiological and bacteriological responses were similar in both groups. There was no increase in the side-effects due to bromhexeine and, overall, its use can be recommended in the treatment of acute lower respiratory infections.

AB - Bromhexeine has been widely used as an adjunct in the management of lower respiratory infections and is usefulin altering the physical characteristics of sputum. Its effect on the sputum penetration of an antibiotic has been sparsely studied. The present study highlights the improvement in sputum amoxycillin (amoxy) levels when a combination tablet, amoxy 500 mg plus bromhexeine 8 mg, is administered as compared to plain amoxy 500 mg. Sputum amoxy levels were significantly higher in the combination group (0.674 ± 0.588 μg ml − ) as compared to 0.272±0.19 μg ml −1 in the amoxy group (P=0.028). The clinical responses assessed by the physician as well as the patient were significantly better in the amoxy plus bromhexeine group as compared to the amoxy group. The radiological and bacteriological responses were similar in both groups. There was no increase in the side-effects due to bromhexeine and, overall, its use can be recommended in the treatment of acute lower respiratory infections.

UR - http://www.scopus.com/inward/record.url?scp=0026506316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026506316&partnerID=8YFLogxK

U2 - 10.1016/S0954-6111(06)80233-7

DO - 10.1016/S0954-6111(06)80233-7

M3 - Article

C2 - 1615182

AN - SCOPUS:0026506316

VL - 86

SP - 157

EP - 160

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 2

ER -